TrialFind
Saved trials
Back to results
Completed
Phase 3
Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes
NCT00120536
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Novartis Pharmaceuticals
East Hanover, New Jersey, United States
View on ClinicalTrials.gov
Official details
Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes — TrialFind